Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011 Jun 30; 364(26):2507-16.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.